PARP inhibition leads to double-stranded DNA breaks during replication, and persistent DNA lesions normally repaired by homologous recombination (HR), causing apoptosis of the BRCA-deficient cancer cells (2, 3). This evidence concerns the gene PARP1 and cancer.